Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:228-234

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Z.-Q.
Right arrow Articles by Carey, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Z.-Q.
Right arrow Articles by Carey, R. M.

(Hypertension. 1997;29:228.)
© 1997 American Heart Association, Inc.


Arthur C. Corcoran Memorial Lecture

Intrarenal Dopamine Production and Distribution in the Rat

Physiological Control of Sodium Excretion

Zhi-Qin Wang; Helmy M. Siragy; Robin A. Felder; Robert M. Carey

From the Departments of Medicine and Pathology (R.A.F.), University of Virginia Health Sciences Center, Charlottesville.

Correspondence to Dr Robert M. Carey, Box 395, University of Virginia Health Sciences Center, Charlottesville, VA 22908

Dopamine (DA), produced by the renal proximal tubule, has been demonstrated as an intrarenal paracrine hormone mediating diuresis and natriuresis. The precise mechanism by which DA exerts its cell-to-cell action is not fully understood. In the present study, renal interstitial fluid (RIF) DA (by in vivo microdialysis) and urinary DA excretion (UDAV) were compared in anesthetized rats on either normal (0.28% NaCl, NS) or high (4.0% NaCl, HS) sodium balance and in response to acute {gamma}-L-glutamyl-L-dopa (gludopa) administration. Urine flow (UV) and sodium excretion (UNaV) in HS were greater than in NS rats. UDAV was increased in HS compared with NS rats. RIF DA was significantly lower in HS than NS rats. Gludopa at 3, 5, and 7.5 nmol/kg (IV bolus) produced a larger increase in UDAV than RIF DA. Only the highest dose of gludopa (7.5 nmol/kg), which resulted in a 7.3-fold increase in UDAV and 1.7-fold increase in RIF DA, was associated with significant diuresis and natriuresis. Cortical and medullary blood flow remained unchanged after gludopa (7.5 nmol/kg) administration, while angiotensin II (100 ng·kg-1·min-1) induced significant reduction in cortical and medullary blood flow. Prior bilateral renal denervation did not have a significant effect on basal DA levels (RIF DA and UDAV) or gludopa-induced DA production or natriuresis and diuresis. These data demonstrated that both chronic sodium loading and acute gludopa administration stimulated renal DA production and release predominantly into the tubule lumen, where DA had a direct tubule action in the control of UNaV. Renal DA production and its renal effects were not significantly regulated by renal sympathetic nerve activity.


Key Words: dopamine • extracellular space • gludopa • kidney • microdialysis • sodium

Abbreviations: DA = dopamine • gludopa = {gamma}-L-glutamyl-L-dopa • HS = high-salt diet • NE = norepinephrine • NS = normal-salt diet • RIF = renal interstitial fluid • UDAV = urinary DA excretion • UNaV = urinary sodium excretion • UV = urinary flow rate




This article has been cited by other articles:


Home page
HypertensionHome page
S. H. Padia, B. A. Kemp, N. L. Howell, J. J. Gildea, S. R. Keller, and R. M. Carey
Intrarenal Angiotensin III Infusion Induces Natriuresis and Angiotensin Type 2 Receptor Translocation in Wistar-Kyoto but not in Spontaneously Hypertensive Rats
Hypertension, February 1, 2009; 53(2): 338 - 343.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Maurel, O. Spreux-Varoquaux, F. Amenta, S. K. Tayebati, D. Tomassoni, M.-H. Seguelas, A. Parini, and N. Pizzinat
Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1592 - F1598.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Zeng, Z. Wang, U. Hopfer, L. D. Asico, G. M. Eisner, R. A. Felder, and P. A. Jose
Rat Strain Effects of AT1 Receptor Activation on D1 Dopamine Receptors in Immortalized Renal Proximal Tubule Cells
Hypertension, October 1, 2005; 46(4): 799 - 805.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. R. Garrett, H. Meng, J. P. Rapp, and B. Joe
Locating a Blood Pressure Quantitative Trait Locus Within 117 kb on the Rat Genome: Substitution Mapping and Renal Expression Analysis
Hypertension, March 1, 2005; 45(3): 451 - 459.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose
Functional genomics of the dopaminergic system in hypertension
Physiol Genomics, November 17, 2004; 19(3): 233 - 246.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Zeng, Y. Luo, L. D. Asico, U. Hopfer, G. M. Eisner, R. A. Felder, and P. A. Jose
Perturbation of D1 Dopamine and AT1 Receptor Interaction in Spontaneously Hypertensive Rats
Hypertension, October 1, 2003; 42(4): 787 - 792.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Bianchi, M.-H. Seguelas, A. Parini, and C. Cambon
Activation of Pro-Apoptotic Cascade by Dopamine in Renal Epithelial Cells is Fully Dependent on Hydrogen Peroxide Generation by Monoamine Oxidases
J. Am. Soc. Nephrol., April 1, 2003; 14(4): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Efendiev, A. M. Bertorello, R. Zandomeni, A. R. Cinelli, and C. H. Pedemonte
Agonist-dependent Regulation of Renal Na+,K+-ATPase Activity Is Modulated by Intracellular Sodium Concentration
J. Biol. Chem., March 22, 2002; 277(13): 11489 - 11496.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Carey
Renal Dopamine System: Paracrine Regulator of Sodium Homeostasis and Blood Pressure
Hypertension, September 1, 2001; 38(3): 297 - 302.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Luippold, M. Beilharz, and B. Muhlbauer
Reduction of glomerular hyperfiltration by dopamine D2-like receptor blockade in experimental diabetes mellitus
Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1350 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Feraille and A. Doucet
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Physiol Rev, January 1, 2001; 81(1): 345 - 418.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Wang, T. J. Berndt, J. M. Gross, M. A. Peterson, M. J. So, and F. G. Knox
Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R248 - R254.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z.-Q. Wang, R. A. Felder, and R. M. Carey
Selective Inhibition of the Renal Dopamine Subtype D1A Receptor Induces Antinatriuresis in Conscious Rats
Hypertension, January 1, 1999; 33(1): 504 - 510.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Ozono, D. P. O'Connell, Z.-Q. Wang, A. F. Moore, H. Sanada, R. A. Felder, and R. M. Carey
Localization of the Dopamine D1 Receptor Protein in the Human Heart and Kidney
Hypertension, September 1, 1997; 30(3): 725 - 729.
[Abstract] [Full Text]